Venous Thromboembolism (VTE)
A worldwide challenge for care environments.
VTE represents a serious and widespread clinical challenge:
- There are 10 million cases of VTE reported worldwide every year,1 yet VTE-related death is a largely undocumented, but preventable medical condition
- It is responsible for more deaths in Europe than breast cancer, prostate cancer, HIV AIDS, and traffic accidents combined2
- Around 30% of patients will die within 30 days of VTE while 25% of unexpected inpatient deaths are diagnosed with PE at autopsy3
- Around 1/3 of patients with DVT develop post-thrombotic syndrome suffering swelling and pain3 and, for many (25%)4, the resultant chronic ulceration is associated with substantial on-going treatment costs5
- In the US, up to $19.1 billion is spent on treatment of long-term complications every year following VTE6